Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup

The Journal of Urology
J I EpsteinP C Walsh

Abstract

Previously we showed that in cases of stage A prostatic cancer, if the tumor involved 5 per cent or less of the tissue and was not high grade (stage A1), only 2 per cent of the tumors progressed at 4 years. The current study investigated a larger group of 94 men with stage A1 disease and extended followup. While 26 men (mean age 75 years) died of other causes less than 4 years after diagnosis, of the 50 men who remained at risk 8 years or longer from the time of diagnosis 8 (16 per cent) had progression of disease. The intervals from diagnosis to progression ranged from 3.5 to 8 years, with 6 of the 8 patients dying of the cancer. Neither volume nor grade predicted progression, since of the 8 tumors that progressed 4 involved less than 1 per cent of the tissue and 6 were low grade. Based on these findings we conclude that stage A1 tumors progress at longer intervals from diagnosis and at lower frequency than stage A2 tumors. However, patients with stage A1 disease are not entirely free of risk of progression, and because 16 per cent of the men in this study who were at risk 8 years or longer experienced progression this factor must be recognized in the management of young men with stage A1 tumors.

References

Sep 1, 1976·The Journal of Urology·N M Khalifa, W D Jarman
Apr 1, 1976·The Journal of Urology·R BarnesR Rosenquist
Mar 1, 1986·The American Journal of Surgical Pathology·W M MurphyL Tatum
May 1, 1974·The Journal of Urology·R J CorreaJ T Mason
Feb 1, 1967·The Journal of Urology·G T MellingerJ Bailar
Dec 1, 1983·British Journal of Urology·L L BeynonG D Chisholm
Aug 27, 1955·Journal of the American Medical Association·L F GREENE, H B SIMON
Nov 1, 1961·The Journal of Urology·T R MONTGOMERYA M LEWIS
May 1, 1951·The Journal of Urology·R M NESBIT, W C BAUM

❮ Previous
Next ❯

Citations

Dec 1, 1987·Postgraduate Medical Journal·P H Smith, T G Armitage
Aug 1, 1987·Cancer·W J Catalona
Jan 1, 1995·Seminars in Surgical Oncology·D R GreeneP T Scardino
Mar 1, 1995·International Journal of Urology : Official Journal of the Japanese Urological Association·M AmakasuJ Shimazaki
Nov 1, 1993·The Journal of Urology·J N Kabalin
Jan 1, 1995·Seminars in Surgical Oncology·U E Studer
Jan 1, 1995·International Urology and Nephrology·H ItoK Nagao
Oct 13, 1994·The New England Journal of Medicine·W J Catalona
Aug 1, 1993·British Journal of Urology·G Waaler, A E Stenwig
Jan 18, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Naruyasu MasueYoshito Takahashi
Mar 2, 2011·Current Opinion in Urology·Umberto Capitanio
Mar 28, 2020·Research and Reports in Urology·Amir Reza AbediFarzad Allameh
Jan 1, 1992·The Prostate. Supplement·M S Soloway, J E Altwein
Jul 1, 1991·The Journal of Urology·T J KinahanA D Manson
Jan 1, 1992·The Prostate. Supplement·L J Denis
May 1, 1990·British Journal of Urology·M C Bishop
Sep 1, 1988·The Journal of Urology·D F PaulsonP J Walther
Dec 1, 1988·The Journal of Urology·B A Lowe, M B Listrom
Dec 1, 1988·The Journal of Urology·J Adolfsson, B Fåhraeus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.